MARCO ISLAND, FL, February 26, 2020 – Early users presented data on MGI’s new CoolMPS™ antibody-based sequencing chemistry and on the company’s DNBSEQ™ platform this week at the Advances in Genome Biology and Technology (AGBT) annual conference. MGI recently announced commercial availability of its sequencing instruments and reagent kits in the United States based on the innovative CoolMPS™sequencing chemistry, starting in April of this year. At AGBT, MGI hosted technology talks with...

In response to the development of new coronavirus epidemics, improving sample detection throughput is a top priority. Nucleic acid extraction through an automated sample preparation system can optimize key speed-limiting steps in the detection process and increase the speed of large-scale sample detection as a whole. At present, two automated sample preparation systems: MGISP-960 and MGISP-100 have obtained NMPA certification. Among them, the throughput of MGISP-960 has been upgraded from...

MGI responded today to a motion filed by Illumina in the US District Court for the Northern District of California for a preliminary injunction to try to prevent MGI from distributing sequencers in the US, saying Illumina’s motion is without merit. Illumina’s motion for a preliminary injunction is not directed to MGI’s novel CoolMPS reagent kits or the use of MGI’s sequencers with the CoolMPS reagent kits. Rather, Illumina’s motion is directed at preventing even minimal use of MGI...

New high-performance chemistry combined with PCR-free DNBSEQ nanoarray platform delivers higher quality and more sequencing reads SAN JOSE, CA, Feb. 21, 2020– MGI, part of global genomics leader BGI Group, today announced the commercial availability of its sequencing instruments and reagent kits in the United States based on MGI’s innovative CoolMPS™sequencing chemistry, starting in April of this year. MGI is planning to roll out its G series DNBSEQ sequencers first in Q2 and then its...

The nucleic acid detection technology based on real-time fluorescent RT-PCR method has played an important role in the rapid identification and diagnosis of coronaviruses. However, to study the origin of coronaviruses, their evolution and pathogenic mechanisms, it is necessary to obtain complete viral genome information, which requires high-throughput sequencing and viral sequence assembly. In order to fully reveal the relevant features of the new coronavirus, MGI can provide integrated s...

Remote ultrasonic robot made by MGI On February 16th, the "Remote Ultrasound Robot" independently developed by MGI Remote Ultrasound Diagnostic System was delivered to Wuhan Huangpi Fangcai Hospital; on February 17, the remote ultrasonic robot was delivered to Lei Shenshan Hospital. As of February 18, all the remote ultrasound equipment headed to the epidemic area have completed the installation, commissioning and training, and quickly supported the ultrasound inspection work in the epide...